Ken‐ryu Han

3.7k total citations
37 papers, 2.2k citations indexed

About

Ken‐ryu Han is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Ken‐ryu Han has authored 37 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 14 papers in Surgery and 14 papers in Oncology. Recurrent topics in Ken‐ryu Han's work include Renal cell carcinoma treatment (20 papers), Bladder and Urothelial Cancer Treatments (10 papers) and Renal and related cancers (8 papers). Ken‐ryu Han is often cited by papers focused on Renal cell carcinoma treatment (20 papers), Bladder and Urothelial Cancer Treatments (10 papers) and Renal and related cancers (8 papers). Ken‐ryu Han collaborates with scholars based in United States, Netherlands and Germany. Ken‐ryu Han's co-authors include Arie S. Belldegrun, Robert A. Figlin, Allan J. Pantuck, Amnon Zisman, Hyung L. Kim, Matthew Bui, Jonathan Said, Frederick J. Dorey, Barbara J. Gitlitz and Danielo Garcia de Freitas and has published in prestigious journals such as Cancer, Clinical Cancer Research and The Journal of Urology.

In The Last Decade

Ken‐ryu Han

37 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ken‐ryu Han United States 22 1.6k 1.1k 773 512 393 37 2.2k
Hervé Lang France 30 1.9k 1.2× 1.4k 1.3× 705 0.9× 507 1.0× 481 1.2× 94 2.7k
Laurent Zini France 26 1.1k 0.7× 783 0.7× 781 1.0× 274 0.5× 175 0.4× 47 1.7k
E. Jason Abel United States 28 1.9k 1.2× 1.2k 1.1× 718 0.9× 514 1.0× 472 1.2× 118 2.5k
Melanie Bernstein United States 25 1.3k 0.8× 741 0.7× 672 0.9× 386 0.8× 299 0.8× 74 1.8k
Jonas Busch Germany 26 1.1k 0.7× 1.0k 0.9× 452 0.6× 716 1.4× 263 0.7× 109 2.2k
Jinsoo Chung South Korea 23 979 0.6× 493 0.5× 634 0.8× 325 0.6× 449 1.1× 143 1.7k
R. J. Amato United States 20 943 0.6× 779 0.7× 816 1.1× 442 0.9× 588 1.5× 68 2.0k
Nicolette Janzen United States 17 1.2k 0.7× 955 0.9× 415 0.5× 439 0.9× 246 0.6× 47 1.8k
Ryoichi Nakanishi Japan 26 1.5k 0.9× 436 0.4× 800 1.0× 210 0.4× 677 1.7× 190 2.4k
Armelle Caty France 20 993 0.6× 558 0.5× 1.1k 1.4× 363 0.7× 751 1.9× 47 2.0k

Countries citing papers authored by Ken‐ryu Han

Since Specialization
Citations

This map shows the geographic impact of Ken‐ryu Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken‐ryu Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken‐ryu Han more than expected).

Fields of papers citing papers by Ken‐ryu Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken‐ryu Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken‐ryu Han. The network helps show where Ken‐ryu Han may publish in the future.

Co-authorship network of co-authors of Ken‐ryu Han

This figure shows the co-authorship network connecting the top 25 collaborators of Ken‐ryu Han. A scholar is included among the top collaborators of Ken‐ryu Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken‐ryu Han. Ken‐ryu Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Klatte, Tobias, Ken‐ryu Han, Jonathan Said, et al.. (2008). Pathobiology and prognosis of chromophobe renal cell carcinoma. Urologic Oncology Seminars and Original Investigations. 26(6). 604–609. 56 indexed citations
2.
Bui, Matthew, Harri Visapää, David B. Seligson, et al.. (2004). PROGNOSTIC VALUE OF CARBONIC ANHYDRASE IX AND KI67 AS PREDICTORS OF SURVIVAL FOR RENAL CLEAR CELL CARCINOMA. The Journal of Urology. 171(6 Part 1). 2461–2466. 146 indexed citations
3.
Shvarts, Oleg, Ken‐ryu Han, John S. Lam, & Arie S. Belldegrun. (2004). Primary leiomyosarcoma of the inferior vena cava presenting as a renal mass.. PubMed. 6(1). 39–42. 8 indexed citations
4.
5.
Han, Ken‐ryu, Nicolette Janzen, Hyung L. Kim, et al.. (2004). Cystic renal cell carcinoma: Biology and clinical behavior. Urologic Oncology Seminars and Original Investigations. 22(5). 410–414. 62 indexed citations
6.
Kim, Hyung L., Ken‐ryu Han, Amnon Zisman, Robert A. Figlin, & Arie S. Belldegrun. (2004). Cachexia-Like Symptoms Predict a Worse Prognosis in Localized T1 Renal Cell Carcinoma.. The Journal of Urology. 171(5). 1810–1813. 59 indexed citations
7.
Ankem, Murali K., Ken‐ryu Han, Victor Hartanto, et al.. (2004). Routine pouchograms are not necessary after continent urinary diversion. Urology. 63(3). 435–437. 4 indexed citations
8.
Seligson, David B., Allan J. Pantuck, Xueli Liu, et al.. (2004). Epithelial Cell Adhesion Molecule (KSA) Expression. Clinical Cancer Research. 10(8). 2659–2669. 100 indexed citations
9.
Han, Ken‐ryu, Allan J. Pantuck, & Arie S. Belldegrun. (2003). Basic Biology and Clinical Behavior of Renal Cell Carcinoma. Cancer treatment and research. 116. 69–89. 1 indexed citations
10.
Leibovich, Bradley C., Ken‐ryu Han, Matthew Bui, et al.. (2003). Scoring algorithm to predict survival after nephrectomy and immunotherapy in patients with metastatic renal cell carcinoma. Cancer. 98(12). 2566–2575. 159 indexed citations
11.
Pantuck, Allan J., Amnon Zisman, Debby H. Chao, et al.. (2003). Renal cell carcinoma with retroperitoneal lymph nodes. Cancer. 97(12). 2995–3002. 128 indexed citations
12.
Bui, Matthew, David B. Seligson, Ken‐ryu Han, et al.. (2003). Carbonic Anhydrase IX Is an Independent Predictor of Survival in Advanced Renal Clear Cell Carcinoma. 9(2). 802–811. 9 indexed citations
13.
Han, Ken‐ryu, Allan J. Pantuck, Matthew Bui, et al.. (2003). Number of metastatic sites rather than location dictates overall survival of patients with node-negative metastatic renal cell carcinoma. Urology. 61(2). 314–319. 93 indexed citations
14.
Janzen, Nicolette, Sherelle Laifer‐Narin, Ken‐ryu Han, et al.. (2003). Emerging technologies in uroradiologic imaging. Urologic Oncology Seminars and Original Investigations. 21(5). 317–326. 9 indexed citations
15.
Kim, Hyung L., Ken‐ryu Han, & Arie S. Belldegrun. (2003). Late relapse of germ-cell tumor.. PubMed. 5(3). 207–8. 1 indexed citations
16.
Han, Ken‐ryu. (2002). Tumor markers for the early detection of bladder cancer. Frontiers in bioscience. 7(5). e19–26. 7 indexed citations
17.
Ankem, Murali K., Victor Hartanto, Michael Perrotti, et al.. (2002). Implications of radioactive seed migration to the lungs after prostate brachytherapy. Urology. 59(4). 555–559. 48 indexed citations
18.
Hartanto, Victor, et al.. (2001). Endoscopic retrieval of retained Jackson-Pratt drain. Urology. 57(5). 973–974. 12 indexed citations
19.
Bui, Matthew, Amnon Zisman, Allan J. Pantuck, et al.. (2001). Prognostic factors and molecular markers for renal cell carcinoma. Expert Review of Anticancer Therapy. 1(4). 565–575. 24 indexed citations
20.
Han, Ken‐ryu, et al.. (1999). Behçet’s syndrome with left ventricular aneurysm and ruptured renal artery pseudoaneurysm. Urology. 54(1). 162–162. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026